Skip to content
10-K

Annual Report

Nuvation Bio Inc. NUVB

0001193125-26-085584

← back to feed
Filed
Mar 2, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 341.54K sh
Shares Diluted FY 2025 · Dec 31, 2024 268.77K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$173.43M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$130.41M
Long Term Debt FY 2025 · Dec 31, 2025 $47.21M
Short Term Debt FY 2025 · Dec 31, 2025 $5.72M
Short Term Debt FY 2025 · Dec 31, 2024 $6.28M
Cash And Equivalents FY 2025 · Dec 31, 2025 $164.09M
Cash And Equivalents FY 2025 · Dec 31, 2024 $35.72M
Stockholders Equity FY 2025 · Dec 31, 2025 $305.72M
Stockholders Equity FY 2025 · Dec 31, 2024 $463.79M
Stockholders Equity FY 2025 · Dec 31, 2023 $605.12M
Current Liabilities FY 2025 · Dec 31, 2025 $82.23M
Current Liabilities FY 2025 · Dec 31, 2024 $58.24M
Total Liabilities FY 2025 · Dec 31, 2025 $289.11M
Total Liabilities FY 2025 · Dec 31, 2024 $76.84M
Current Assets FY 2025 · Dec 31, 2025 $571.52M
Current Assets FY 2025 · Dec 31, 2024 $526.26M
Total Assets FY 2025 · Dec 31, 2025 $594.82M
Total Assets FY 2025 · Dec 31, 2024 $540.63M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.60
Eps Diluted FY 2025 · Dec 31, 2024 −$2.11
Eps Basic FY 2025 · Dec 31, 2025 −$0.60
Eps Basic FY 2025 · Dec 31, 2024 −$2.11
Sga Expense FY 2025 · Dec 31, 2025 $151.56M
Sga Expense FY 2025 · Dec 31, 2024 $69.23M
Rd Expense FY 2025 · Dec 31, 2025 $115.11M
Rd Expense FY 2025 · Dec 31, 2024 $99.12M
Net Income FY 2025 · Dec 31, 2025 −$204.63M
Net Income FY 2025 · Dec 31, 2024 −$567.94M
Operating Income FY 2025 · Dec 31, 2025 −$213.06M
Operating Income FY 2025 · Dec 31, 2024 −$592.63M
Revenue FY 2025 · Dec 31, 2025 $62.9M
Revenue FY 2025 · Dec 31, 2024 $7.87M